

















Bachelor of Science, Nursing 




Master of Science, Nursing 




A doctoral project submitted in partial fulfillment  
of the requirements for the  
 
 
Doctor of Nursing Practice 
 
 
School of Nursing 
Department of Health Sciences 
The Graduate College 
 
 























Copyright 2020 Teresa Praus 
 





Doctoral Project Approval 
The Graduate College 
The University of Nevada, Las Vegas 
        
March 24, 2020
This doctoral project prepared by  
Teresa Praus 
entitled  
Management of Atrial Fibrillation with Smartphone Technology 
is approved in partial fulfillment of the requirements for the degree of 
Doctor of Nursing Practice 
School of Nursing 
 
                
Mary Bondmass, Ph.D.       Kathryn Hausbeck Korgan, Ph.D. 
Examination Committee Chair      Graduate College Dean 
 
Du Feng, Ph.D.  
Examination Committee Member 
        
Ju-Yeon Jo, Ph.D. 






Atrial fibrillation is the most common arrhythmia affecting over six million people; it is 
predicted to increase two-fold by the year 2050.  This arrhythmia results in a lack of 
atrial/ventricular communication, accompanied by ineffective atrial contraction, suboptimal 
ventricular filling, and thrombus formation.  This may lead to stroke, and ultimately heart failure.   
The current economic burden related to the complications of atrial fibrillation is estimated to be 
greater than $6 billion annually with potentially catastrophic events, further increasing 
expenditure.  
When patients experience symptoms related to atrial fibrillation, it is common for them to 
present to a hospital emergency department.  These visits, many of which may not be necessary, 
can be costly and often are anxiety-provoking events.  If a patient’s rhythm and rate can be 
managed virtually, via the Internet, patients’ anxiety may be decreased, satisfaction increased, 
and the use of costly resources reduced.   
Available research suggests that management of atrial fibrillation via the Internet is a  
useful adjunct in reducing overutilization of resources and improving the quality of life by 
decreasing anxiety.  Moreover, with the addition of virtual visits, access to a cardiology provider 
is improved, thereby increasing patient satisfaction.   
The purpose of this Doctor of Nursing Practice (DNP) project was to improve patient 
outcomes and reduce resource utilization related to atrial fibrillation.  Over eight weeks, 43 
patients meeting pre-determined criteria, were given a KardiaMobile® device and provided 
education on its use.  This device is designed to pair with a mobile phone application, which is 





strip, equivalent to Lead I on a traditional 12-lead electrocardiogram, converted to pdf format, 
then emailed to a provider for review.  Using the treatment algorithm developed by this DNP    
student, coupled with the clinical judgment of symptomatology, episodic management 
commenced with a phone call or a virtual ‘face-to-face’ visit.   
There was no statistical significance demonstrated in pre- and post- HADS scores for 
anxiety or depression; however, the results of the internal satisfaction survey revealed a 
reduction in self-reported anxiety and increased satisfaction with the ability to communicate with 
the healthcare team and improved access to a cardiology provider.  Lastly, patients felt this 
program reduced unnecessary ER visits and felt empowered to manage their healthcare concerns.  
The implications of this project also extended to rural areas, where nearby acute care facilities 
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Management of Atrial Fibrillation with Smartphone Technology 
Chapter I 
Introduction 
Atrial fibrillation (AF) is the most common cardiac arrhythmia (Morillo, Banerjee, Perel, 
Wood, and Jouven, 2017); it occurs when the upper chambers of the heart (atria), do not 
communicate effectively with the bottom chambers of the heart (ventricles).  The lack of 
atrial/ventricular communication results in an ineffective atrial contraction and suboptimal 
ventricular filling, which can further lead to heart failure (HF) and hemodynamic compromise. 
Consequences of AF and hemodynamic compromise vary from person to person but can 
manifest as symptoms of dyspnea, chest discomfort, palpitations, fatigue, hypotension, or 
syncope.  Moreover, AF predisposes patients to cardiac thrombus formation, placing them at 
higher risk for stroke.  Stroke and HF further increase the risk of morbidity and mortality related 
to AF and reduction of the afflicted person's quality of life (Morillo et al., 2017). 
Problem and Significance  
The current number of people in the United States (U.S.) with AF is estimated to be 
between 2.7-6.1 million and is predicted to increase two-fold by the year 2050 (Morillo et al., 
2017).  The current economic burden, solely related to AF, is estimated to be over $6 billion 
annually; as the number of patients double, it is reasonable to assume the economic burden will 
concomitantly increase (Thompson et al., 2014).   
When a patient becomes symptomatic with AF, they generally present to an acute care 
facility, such as an urgent care (UC) or an emergency room (ER); this is a common occurrence 






the outpatient setting, and would not require a visit to a brick-and-mortar clinic for an in-person 
evaluation, as long as rhythm and rate can be assessed, and symptoms managed virtually or at a 
distance (Anczykowski et al., 2016). 
Asymptomatic AF is another concern that has become increasingly common in the aging 
population.  Atrial fibrillation may or may not become evident before a catastrophic event; 
therefore, the World Heart Federation (WHF) (2017) recommends AF screening for all patients, 
65 years of age or older, with or without risk factors.  The lack of screening is particularly 
problematic in rural, disadvantaged, or underserved areas (Morillo et al., 2017).    
The use of mobile technology in healthcare is widely recognized to decrease geographical 
barriers for access to care and clinical oversight.  One such mobile technology is AliveCor’s 
KardiaMobile® (KM) device.  The KM device provides a transmittable electrocardiogram 
(ECG) to a health care provider for AF screening and management at a distance.  This DNP 
student utilized the KM device to evaluate for AF. 
Purpose 
The purpose of this DNP project was to improve patient outcomes and reduce resource 
utilization related to atrial fibrillation.  Patient outcomes include a reduction in the level of 
anxiety and improved satisfaction with access to care; resource utilization is defined as atrial 









Review of the Literature  
This chapter presents an extensive literature review.  A search of several databases was 
conducted in pursuit of studies published within the last five years and some classical and 
historical for perspective.  The five-year time-frame was chosen to correspond to the timing of 
the Food and Drug Administration (FDA) approval of the KM mobile application as well as the 
growing acceptance of telehealth or health management from a distance. 
The Cumulative Index of Nursing and Allied Health Literature (CINAHL), Cochrane 
Database, and Google Scholar were searched using keywords: atrial fibrillation, afib, atrial 
arrhythmia, anxiety, AliveCor, KardiaMobile®, KardiaBand®, portable EKG, portable ECG, 
mobile application, mobile app, smartphone, telehealth, telemonitoring, telemedicine, virtual 
visits, mobile technology, innovative technology, digital technology, unnecessary 
hospitalizations, overutilization of ERs.  There was a paucity of information related to innovative 
technology cross-referenced with atrial fibrillation; however, there were a few studies with small 
cohorts that lend support for this proposal.     
Emergency Room Overutilization.  As previously noted, AF is the most common 
cardiac arrhythmia resulting in a five-fold increased risk of ischemic stroke with concomitant 
healthcare expenditure of more than $6.65 billion within the U.S. alone, 23% of which is driven 
by outpatient testing and management (Garabelli, Stavrakis, & Po, 2017).   Patients presenting to 
the ER in AF with a rapid ventricular response (RVR) and subsequent hospitalizations are 






Demeester et al. (2018) developed an algorithm for patients presenting to an acute care 
facility to further decrease decompensation after discharge.  Upon discharge, patients received 
rate-controlling medication prescriptions, AF educational material, an outpatient follow-up 
appointment within three days, and indications of when to return to the ER.  This algorithm 
eliminated the inpatient cardiology consult, and admission rates decreased from 80.4% to 67.4% 
(Demeester et al., 2018). 
History and Development of Innovative Technology.  Electrocardiography evolved 
with the detection of changing cardiac electrical potentials in 1887 by Ludwig and Waller.  
Recordings of these electrical signals with the use of a string galvanometer by Einthoven, the 
"father of electrocardiography," followed in 1901.  Soon thereafter, the portable radio receiver 
tape-recording unit was developed by Norman Holter in 1947, and mobile cardiac monitoring 
was established (Garabelli et al., 2017).  The next progression in mobile cardiac monitoring was 
the event monitor (EM), whereas previously the HM was worn for 24 hours, the EM was worn 
up to 30 days.  Real-time telemetry was the next evolution followed by implantable loop 
recorders (ILRs) and, most recently, smartphone technology.   
Cajita, Gleason, and Han (2016) conclude from their systematic review of mobile health-
based heart failure interventions, there is a need to appeal to a target patient population; however, 
their results were limited due to the use of older mobile phone technology and a high attrition 
rate.  As noted, the smartphone has been demonstrated as an inexpensive screening tool.  
Mcmanus et al. (2016) investigated a mobile application robust enough to detect cardiac 
arrhythmia out-of-the-box using the camera flash on a smartphone.  A combination of pattern 






used to accomplish this task.  The placement of a finger on the iPhone 4s camera lens for two 
minutes allows for a video to be obtained and then analyzed by an algorithm.  The algorithm 
performs a beat-to-beat analysis from the patient's pulse, which is then able to distinguish AF 
from sinus rhythm (SR) (Mcmanus et al., 2016).   
Jaakkola et al. (2018) evaluated the reliability of the Sony Xperia smartphone to detect 
AF without the use of additional hardware.  A 5-lead ECG recording strip demonstrated high 
sensitivity and specificity at both three minutes and 60-second recordings.  Olsson and Engdahl 
(2016) were successful in demonstrating AF detection rates with ECG recordings using a 
handheld-monitor compared to a traditional 48-hour Holter monitor (HM).   
Anczykowski et al. (2016) studied real-time ECG recordings transmitted via telephone to 
a center in Germany.  Palpitations were the most frequently reported symptom.  Of 790 patients, 
11,775 ECGs were recorded, and 11,029 of these ECGs were of acceptable quality.  Atrial 
fibrillation was revealed in 110 (14%) people, of whom 40% were newly diagnosed.   
  A meta-analysis conducted by Widmer et al. (2015) reports a benefit predominantly for 
web-based, telehealth, and texting approaches to intervention with nearly a 40% relative risk 
reduction in cardiovascular outcomes.  Of particular note, digital health innovation (DHI), in and 
of itself, does not directly reduce risk; however, the observed benefits likely reflect increased 
adherence to evidence-based preventive therapy. 
Quality of Scientific Evidence .  In 2015, over 40,000 mobile applications were available 
in the Apple App Store alone; very few of these applications were formally or scientifically 
evaluated (O'Neil et al., 2017).  The lack of formal scientific evaluative evidence of DHI is 






The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 
uses an evidence-based minimum set of items for reporting on systematic reviews and meta-
analyses of randomized controlled trials (RCTs) and evaluation of interventions.  The 
Consolidated Standards of Reporting Trials of Electronic and Mobile Health Applications and 
online Telehealth (CONSORT-eHEALTH) guidelines, developed in 2010, were created to 
promote improved quality of reporting, determine the impact on populations, review for potential 
scale-up, and how to translate research findings into the clinical environment (O'Neil et al., 
2017).    
The CONSORT-eHEALTH guidelines placed special consideration on the 1) 
intervention being developed for evaluation, 2) participant program access, 3) the DHI itself, 4) 
where the resources were provided to supplement interventions, 5) data collection and storage, 6) 
attrition rates, 7) demographics, and 8) process outcomes (Oneil et al., 2017).   PRIMSA 
combined with the use of a quality framework, such as the Cochrane risk of bias assessment tool, 
and CONSORT-eHEALTH were used to assess the scientific process that guides evidence-based 
practice.  Of the 33 systematic reviews examined, only six reported using the PRISMA 
guidelines.  The Cochrane tool was most commonly used in 10 of the 33 reports, and six made 
no mention of using a quality assessment framework.  Lastly, eliminating bias towards higher 
income and higher educated patients with the use of the World Health Organization's (WHO's) 
evidence checklist allows for transparency, evidence-based strengthening, and population impact 
(Oneil et al., 2017).  Further research is needed to determine what factors influence patients and 






AliveCor Mobile Application.  The AliveCor KM device consists of two electrodes, 
which can be attached on the back of a smartphone case, records a Lead I rhythm strip.  The 
Lead I rhythm strip is then viewed in real-time and can be disseminated to a provider via email.  
(Garabelli et al., 2017).  The KM first received FDA 510k approval in 2012 and was available by 
prescription only in 2013.  The device became available to patients for over-the-counter purchase 
in 2014 (Garabelli et al., 2017).   Smaller studies, with varying comparisons and outcomes, 
supported the use of the KM application (Bumgarner et al.,2018; Halcox et al., 2017). 
Additional Support for Transmittable Technology.  An estimated three million people 
use wearable technology worldwide, and this number is projected to grow to 90 million by 2019.  
(Garabelli et al., 2017).  In 2016, mobile application downloads were estimated at 3.2 billion 
(Coorey, Neubeck, Mulley, & Redfern, 2018).  The usage rate of mobile technology in 2015 for 
the U.S. was 72%, 60% in Europe, and 37% in developing countries such as sub-Saharan Africa, 
South Asia, and parts of Central America; thus, supporting the claim that digital technology is 
further extending its reach (Coorey et al., 2018).   
The International Society for Holter and Noninvasive Electrocardiography (ISHNE) and 
the Heart Rhythm Society (HRS) developed a document that reported a review of contemporary 
ECG monitoring devices.  The conclusion from the ISHNE and HRS report was that 
simultaneous polygraphic monitoring would allow for correlation with arrhythmic events 
providing invaluable data (Locati, 2017).   
Sposato et al. (2015) reported cumulative data in a four-phase meta-analysis, which 
included 144 studies with 11,658 patients.  The proportion of patients diagnosed with AF post-






obtained post ER admission, 5.1% - seen on inpatient telemetry, 10.7% - discovered on HM 30-
days post-hospital discharge, and 16.39% found on external loop recording (Sposato et al., 
2015).  In a smaller systematic review (10 studies, 607 patients), the effectiveness, acceptability, 
and usefulness of mobile applications was undertaken; a decrease in re-hospitalization rates, 
improved disease-specific knowledge, and improved psychosocial well-being was concluded 
despite the limitation of possible over-estimation due to primary reliance on self-report (Coorey 
et al., 2018).   
Summary.  In summarizing the literature review, improvements in technology have 
increased the utilization of mobile devices to deliver care at a distance.  Early detection has 
shown to be an effective intervention to decrease unnecessary visits to ERs and UCs.  Success 
with cardiac conditions in general – and AF in particular – have improved care, reduced 
symptomatology, and improved quality of life.  While commercial bias is a continuing issue, 
careful consideration is given when selecting the appropriate mobile technology for a particular 
patient population; evidence supports the judicial use of mobile technology for patient care.   
Needs Assessment and Description of the Project 
A needs assessment was performed to evaluate “same-day” access problems to 
cardiology providers; it was previously noted that patients would go to a UC clinic or an ER on 
the day that their symptoms occur because they know it would be nearly impossible to get access 
to the cardiology clinic.  The ideal state is where a patient upon experiencing symptoms can be 
evaluated on the same day to eliminate an ER visit.  The difference between this ideal state and 
the status quo is what needs to be addressed.  The patient must be willing to use a device paired 






Furthermore, the question remains if patients are willing to have their symptoms and, 
potentially, medications managed remotely via smartphone or computer.  It was determined that 
the use of the KM device provided patients with a sense of security, and virtually “same-day 
access” to a provider.  The KM device provided patients with a sense of control over their 

























 The conceptual framework adopted for this DNP project is Lakey's (2016) five-stage 
strategy to create change.  In the first stage, termed "cultural preparation," a vision needs to be 
developed by initiative-takers for short-term and long-term goals (Lakey, 2016, p. 301).  The 
initiative-takers are leaders by default.  These initiative-takers see poor access to specialists and 
overutilization of acute care resources; they devise a plan to do something about it.  These first-
stagers initially need to see themselves as a liaison between two worlds – one inhabited by 
healthcare providers and stakeholders, and the other by everyone else (Lakey, 2016).   
In the second stage, "organizational building," the structure and function of an 
organization must be planned and implemented (Lakey, 2016, p. 302).  Various organizational 
units must come together, which include a team for registering patients, a team for assisting 
patients with the use of the KM device, a team for maintaining the Internet platform for face-to-
face encounters, a team for coding and billing, and a team for supervising the operation and 
reporting to senior leadership (Lakey, 2016). 
The third stage - is loosely interpreted - as marketing access.  Mutual benefits given to 
both healthcare providers and patients should be communicated to all stakeholders.  Who and 
what opposes this new methodology of increasing access to healthcare?  Why?  Would they 
rather have the status quo?  If so, how do they benefit from maintaining the status quo?  (Lakey, 
2016). 
Mass adoption is the fourth stage, again loosely interpreted.  Patients, after having 






AF, become spokespersons for this new methodology, of their own volition.  This alternative 
access to healthcare offers unprecedented and unparalleled convenience, as patients stay in the 
comfort of their own homes (Lakey, 2016). 
The final stage is “parallel institution.”  The old order has legitimate structure and 
function; unlike what is suggested by Lakey (2016), mobile technology does not replace the old 
order; instead, it only supplements.  More of the old order will be supplemented as technology is 
further developed; however, it does not take a stretch of the imagination to predict that an in-






















This chapter describes the methods and procedures for this DNP project.  The setting, 
sample, procedure, project tasks, team, instrumentation, and timeline are discussed.  
Additionally, the project sponsor, key stakeholders, along with an organizational assessment, 
resources and supports, risks and threats, and a financial plan, are presented.  
Project The project commenced with the development of a protocol in August 2018.  Once the 
protocol was established, a visual workflow was developed (Appendix A), and the project was 
presented to the Chief of Cardiology and operational leadership.  The Chief Medical Information 
Officer (CMIO) presented the protocol to the Enterprise Sourcing & Procurement (ES&P) 
service team to acquire funding; an amount of $5000 was secured for the project.  Once funding 
was obtained, a meeting was set with Information Technology (IT) security to evaluate the 
cloud-based system in anticipation of its use; however, due to the small sample size, the 
organization elected to wait for the completion of the trial to determine if the return on 
investment would prove worthwhile. 
 Setting.  The setting consists of an outpatient cardiology clinic in combination with the 
use of a virtual clinic platform, and patients’ homes or wherever they choose to transmit data.  
The virtual clinic platform has been in use with the organization’s “On Demand” department for 
the past five years, with more than 25,000 video consultations since its inception.  The first 
cardiology virtual visit took place in March 2019.  This novel approach to care was implemented 
in anticipation of its use with this DNP project.   
 Sample.  The intended convenience sample was made up of 43 eligible adults over the 






There were an additional five patients who were referred from the Chief of Cardiology and her 
partnering nurse practitioner.  Anticipating some attrition, 50 eligible patients were identified and 
invited to participate.  Eligibility criteria included those who:  
 Were established with the organization’s cardiology department. 
 Expressed understanding and willingness to sign informed consent. 
 Owned and verbalized comfort with the use of a smartphone and its applications. 
In addition, the patient must have at least one of the following:  
 A diagnosis of AF. 
 Two or more urgent care and or emergency room visits within the past 12 months.  
 The need for rate control with medication titration.   
 Reestablished sinus rhythm, either by chemical or direct current cardioversion 
(DCCV); to monitor for AF reoccurrence.   
Anyone who had already purchased the KM device was able to submit recordings for 
review; anyone not meeting the above inclusion criteria was excluded. 
Project Tasks.  Project tasks consisted of:  
 IRB approval, which was granted on August 1, 2019 (Appendix B). 
 Sample identification occurred during office visits over the course of several months.   
 A protocol was developed, and education was provided to both patients and staff.  
 A budget of $5000 was procured to purchase the KM devices.   







 The dedicated, shared, email address was then created by the IT team.   
 Personnel was trained on the use of the KM device and NowClinic applications.  
 Meetings with representatives from the AliveCor/KardiaMobile® team, the DNP 
student, and non-licensed support staff were held for training purposes.   
 Visit codes were created for both NowClinic follow-up and KM training for tracking 
purposes within IDX – software used for scheduling and billing.   
 The DNP student met with non-licensed support staff to provide education regarding 
appointment scheduling, within the virtual platform, and the use of NowClinic as this 
was not integrated within IDX.     
 The creation of a coupon code was created to be used to eliminate the NowClinic visit 
copays.  
 Informed consent was obtained from each patient at the time of enrollment.  
 Devices were distributed to patients – with assistance to set up their accounts.  
 A query was submitted to the health information exchange (HIE) department with 
regard to the number of patients that have been assigned a diagnosis code related to 
AF.   
 A query was also submitted to HIE with regard to the number of dollars spent on 
hospitalizations related to AF between the months of June 2017 and May 2018.  
A meeting with all cardiology providers, six cardiologists , and six advanced practice 
clinicians (APCs), was organized to introduce the protocol.  A determination was made, prior to 
initiating the program, that patients would be selected from the panel belonging to the DNP 






this meeting.  To date, two cardiologists and two APCs, including the DNP student, have 
enrolled patients.   
Team.  The team for the project was made up of the DNP student, DNP project chair, 
DNP project committee – which includes a statistician – the Chief of Cardiology, the Director of 
Nuclear Medicine and Anticoagulation Clinic, the Chief Medical Informatics Officer, and non-
licensed support staff.  Each member’s role was defined as:  
 The DNP student, as the project lead, developed, and implemented the project as 
outlined above.    
 The DNP project chair guided and mentored the DNP student throughout the 
implementation of the project and assisted with the attainment of Institutional 
Review Board (IRB) approval.   
 The Chief of Cardiology and Director of Nuclear Medicine and Anticoagulation 
clinic provided support and guided the DNP student with the protocol.  
 The Chief Medical Informatics Officer secured funding for the project.  
 The non-licensed support staff scheduled visits related to the project and provided 
educational assistance with communication via telephone.    
  Procedure.  Patients identified as potential candidates were called or received an email 
outlining the details of the project.  Following informed consent, two applications were 
downloaded onto the smartphone: Kardia and NowClinic.  A baseline rhythm recording was 
obtained, and emailed, during the initial visit.  Demographic information was also collected at 






 A rhythm recording was emailed, at a minimum, once daily to the designated cardiology 
email address; patients understood their transmissions were viewed Monday through Friday 
between the hours of 0800 to 1700.  The patient was instructed to email recordings obtained 
during times in which they experienced symptoms – defined as, but not limited to, chest 
discomfort, shortness of breath, palpitations, lightheadedness, and dizziness.  The patient was 
provided with instructions to proceed to an Urgent Care facility should they experience 
symptoms when the email was not monitored.   
ECG recordings were reviewed and then forwarded to medical records to be scanned in 
the respective patient’s chart.  If the recordings were normal, daily transmissions continued.  If 
abnormal, attempts were made to contact the patient by telephone or email; once contact was 
made, the patient was offered a NowClinic visit, although most were comfortable with phone 
follow up.   
Participants completed two online surveys.  One survey, administered by the 
organization’s patient experience team, assessed satisfaction with access to care, reduction in 
emergency room visits, and a reduction in the level of anxiety.  A link to this survey was emailed 
anonymously to all participants at the end of 8 weeks.  A second tool, the Hospital Anxiety and 
Depression Scale (HADS) is a cost-effective, validated tool that has been used in both the 
hospital and community settings (Snaith, 2003).  This self-rating, screening scale is comprised of 
fourteen questions that facilitate early detection of anxiety and depression (Stern, 2014).  A link 
was emailed to each patient within the first week, and then again at the end of the 8-week period, 
to determine if there was a change in pre- and post- anxiety levels.  For this particular DNP 






 Timeline.  Distribution of the KM devices occurred over several weeks.  This timeframe 
included predetermined dates to assist with the use of the KM device and instruction on how to 
convert the readings to a pdf file.  Unfortunately, due to the prolonged and stringent 
scrutinization of KardiaPro, the cloud-based system used to house ECG recordings, there was a 
delay in shipment of the devices.  Once the determination was made to abort the use of 
KardiaPro, the process moved swiftly.   
 Prior to the end of the Spring 2020 semester, data were collected to evaluate patient 
satisfaction and anxiety.  These data were reviewed to determine if patients experienced an 
improvement in provider access as well as a decrease in the level of anxiety.  Additionally, the 
number of ER admissions and UC visits were queried by extracting data from the electronic 
health record (EHR) using diagnosis codes related to AF. 
Instrument and Outcomes 
Smartphone Technology.  The KM device is portable and meant to be used whenever 
and wherever the patient may be at the time of symptom onset; once the recording has been 
obtained, the patient is able to email a pdf to a dedicated email address, created solely for this 
project.  An additional smartphone application, used for the NowClinic, was downloaded onto 
the patient’s phone, which provided remote access to a cardiology provider. 
Anxiety.  The patients’ level of anxiety was measured using HADS pre- and post-
participation.  Completion of the questionnaire takes approximately 2-5 minutes and can detect 
varying degrees of emotional disorders in adults.  As previously mentioned, the HADS is made 






assessment of depression.  Score calculation and results interpretation indicate the severity of the 
mood disorder.  A copy of the HADS is included as an appendix (Appendix C).  
Satisfaction.  The organizational satisfaction survey is made up of nine questions.  These 
questions address how the patient perceives access and communication with a cardiology 
provider, if unnecessary hospitalization were avoided, and if anxiety levels were decreased.  
Moreover, the patient provided their level of satisfaction had they not been enrolled in this 
project.  A copy of the organization’s patient satisfaction survey is also included as an appendix 
(Appendix D).   
Resource Utilization.  The number of urgent care visits associated with AF, as well as 
AF-related ER visits, were queried over twelve months.  In addition, the internal organizational 
survey queried disposition – where the patient stated they would have sought care – were the 
program not available.  Options for disposition on the survey include an emergency room, urgent 
care, office visit, or done nothing. 
Data Analysis.  All demographic information was obtained from the respective patients’ 
medical records.  Descriptive statistics were used to describe the demographic data and to 
describe the frequency of AF-related ER visits and hospitalizations.  HADS data were converted 
to an interval level score, and pre- and post- data (HADS) were analyzed with a paired t-test.   
Project Sponsor and Key Stakeholders 
  The project sponsor is a for-profit, multispecialty group that is a subsidiary of a large 
healthcare company.  There are 18,659 Nevadans being cared for by the cardiology department.  






providers; collectively, there were 43,054 patient visits in 2018 associated with various cardiac 
disease processes, of which, 10,852 were assigned a diagnosis code related to AF.   
 Internal key stakeholders with a vested interest include the Chief of Cardiology, the 
Director of Nuclear Medicine, and Anticoagulation Clinic – a cardiologist who acts as a mentor 
to the DNP student, the Chief Medical Informatics Officer, and two non-licensed personnel who 
make up the support team.  External key stakeholders include the DNP committee chair, 
committee members, and the patients’ insurance company as there is interest in decreasing the 
cost of treatment as well as increasing access to cardiology providers.  AliveCor, the 
manufacturer of KM, also stands to gain from the success of this project; however, the most 
important stakeholders are the patients.  The patients were the most vested party in this project.  
There is potential to reduce acute care utilization, decrease anxiety, and improve satisfaction 
with access and overall outcomes.   
Organizational Assessment 
  An organizational assessment was conducted of a multi-specialty group in Las Vegas, 
Nevada.  Using the KM technology for same-day access to providers is widely considered as 
cutting-edge.  As such, the organization has a great deal to gain with this project.  If it goes well, 
the organizational reputation will be undoubtedly enhanced.  Even if the project receives only a 
lukewarm response, the organization will be commended for allowing an innovative approach to 
patient care.  In addition to the DNP student, two cardiologists and two support staff members 
were involved with implementing the project.  
Resources and Support.  A budget of $5000 was procured to cover the expense of the 






expense as it is considered part of her graduate study.  The cardiology department absorbed the 
cost and time of support staff.  The time spent by the other two cardiologists was voluntary as 
they are on a relative value unit (RVU) based system for reimbursement.      
Support was obtained from the Chief of Cardiology and the organization’s operational 
leadership to move forward.  A dedicated cardiology email address was created by the 
information technology (IT) team to receive rhythm recordings.  The DNP student was available 
at pre-determined times to assist patients with trouble-shooting, as problems arose, with the use 
of the KM device.   
Communication and support were obtained from the HIE department with regard to data 
that were queried.  Assistance from the patient experience team was obtained to create a brief, 
online survey to provide data to senior leadership concerning patient experience outcomes.  
Permission was obtained, and payment made to utilize the HADS tool. 
Cost-Benefit Analysis.  The Centers for Medicare and Medicaid Services (CMS) 
reported 17.9% ($3.5 trillion) of the U.S. Gross Domestic Product (GDP) was spent on 
healthcare in 2017 (“National Health,” 2018).  Of $3.5 trillion, $6 billion was related to AF, and 
the associated complications (Thompson et al., 2014).   
An analysis of the number of dollars spent on hospitalizations related to AF from June 
2017 through May 2018, obtained from hospital claims data, was more than $4 million.  Upon 
review of claims data from this same period, it was noted that 36 patients had two or more 
hospitalizations; the average cost for each admission was estimated at $7,450.  The total cost for 






collection period, to determine the number of dollars saved in direct proportion to potentially 
reduced ER visits. 
Financial Plan.  A budget of $5000 was awarded by the employer of this DNP student to 
cover the cost of 50 KM devices.  The restriction from using AliveCor’s cloud-based system 
afforded the opportunity to increase the number of devices from 30 to 50.  The total for 50 
devices, at a retail of $99, equates to $4950.00.  A request was made to use 150 HADS surveys; 
the cost to utilize the HADS tool was £150, which equates to $177.12; the DNP student absorbed 
this cost.   
Risks and Threats.  The biggest threat to the project was moving beyond the KardiaPro 
cybersecurity hurdle.  The organization’s cybersecurity department heavily scrutinized the cloud-
based platform, which houses patients’ rhythm recordings.  With this scrutiny came the solution 
to bypass the use of their cloud-based system and have the patient email their recordings directly 
into an email account created within the organization’s firewalls.  Once this decision was made, 
the threat was eliminated.   
Interestingly, whereas KardiaPro was the most significant threat to the project, it could 
have also eliminated the most significant barrier – time management.   KardiaPro has the ability 
to tally recordings with the touch of a button, whereas the DNP student manually interpreted and 
counted each recording.  A significant number of hours were required to over-read and tabulate 
the 1,501 ECG recordings.   
Additionally, KardiaPro has the ability to identify changes in rhythms and the ability to 
send an alert when a change occurs.  In the current state, the DNP student is monitoring all 






arise.  For example, patients with paroxysmal AF can vacillate between AF and SR.  For many, 
this may not be unusual; however, if a patient had a lone episode of AF, 15 years prior – and has 
remained in SR since – it is imperative to acknowledge and expeditiously act upon the change.   
Another threat to the project occurred as the process in vetting KardiaPro resulted in the 
delay of device distribution; as such, the data that were reported were collected at the 8-week 
mark versus the 12-week target.  Lastly, as with any task dealing with human subjects, there is 
always the risk of attrition due to the strict requirements.  Attempts were made to ensure 
participants understood the course of the project and were without any restrictions.  To date, we 
have had one patient voluntarily discontinue the use of the device as he developed complications 







Results of Data Collection and Analyses  
The purpose of this DNP project was to improve patient outcomes and reduce resource 
utilization related to atrial fibrillation.  Patient outcomes include a reduction in the level of 
anxiety and improved satisfaction with access to care; resource utilization is defined as atrial 
fibrillation-related emergency room visits, hospitalizations, and assumed cost savings. This 
chapter presents the project results to include demographics, anxiety and depression, satisfaction 
with access to care, resource utilization, numbers of ECG recordings, satisfaction, and other 
findings. 
Demographic Data.  Demographic data were recorded at the time of enrollment.  
At the end of the eight weeks, of the 43 total patients enrolled, 53% were men (23), and 47% 
(20) were women with a mean age of 66.79 ± 9.78 years (median = 69.00, range = 35 years). The 
cohort was made up of 77% Caucasian, 10% African American, 8% Hispanic, and 5% Asian. 
Moreover, 84% of the patient population resided in Las Vegas, 11% in Henderson, and 5% in 













Table 1: Demographic Data 
 
 
Anxiety and Depression.  A total of 86 HADS surveys were administered; there were 30 
pre-intervention surveys returned, and 21 post-intervention.  Of the 30 pre-intervention surveys, 
18 patients did not have anxiety; nine patients had borderline anxiety, and three patients were 
rated as having abnormal anxiety-related to AF.  Of the 21 post-intervention surveys completed, 
15 did not have anxiety, two were borderline, and four were found to have anxiety.   
While depression was not an outcome of this project, since the HADS provided this 
information, it is presented here.  Three patients were found to be depressed, two had borderline 
depression, and 25 did not have any reported depression.  The post-survey rated two patients as 
having depression – both of whom were already being treated by their primary care provider, two 
patients with borderline depression, and 17 patients without depression.   
The scores from the pre- and post- HADS surveys were analyzed with a paired t-test 
using IBM® SPSS 24.  There was no statistical difference found; however, the results of the 







Table 2: HADS Survey Results  
 
Satisfaction.  Forty-three patient experience surveys were distributed with 33 completed.  
Results revealed that 97% (32) of respondents found value in the pilot’s additional service as 
well as the KM device.  Further, patients who were being monitored had a reduction in self-
reported anxiety.  Using a Likert-scale, with ‘1’ representing no decrease in anxiety, and ‘5’ 
representing a decrease in anxiety; 62% (18) responded the program reduced their anxiety level 
with a ‘5’ rating, and 24% (7) responded with a ‘4’ rating.  When considering the ratings as 












Table 3: Internal Patient-Satisfaction Survey Results  
 
 
Table 4: Internal Patient Satisfaction Survey Binary Results
 
 
Resource Utilization.  According to the patient experience survey, 25% (8) respondents 
reported they would have presented to the urgent care, and 34% (11) indicated they would have 






cohort alone resulted in 11 potential ER diversions and a cost savings of $81,950, using the 
previously calculated average cost for an ER visit. 
 
Table 5: Resource Utilization 
 
 
ECG Recordings.  A total of 1,501 ECG recordings were received and reviewed by the 
DNP student at the end of eight weeks.  There were 710 recordings interpreted as normal sinus 
rhythm, 537 were interpreted as possible atrial fibrillation; of which, 74 had rapid ventricular 
rates (RVRs).  There were 173 unclassified interpretations, 46 bradycardic, 24 tachycardic, eight 
were deemed unclassified – due to artifact – and three recordings were too short to be 
interpreted. 
Of those designated as unclassified, the majority came from two patients.  The first 






first-degree atrioventricular block and left bundle branch block.  These two patients’ recordings 
made up 76 of the 173 unclassified rhythm strips.   
One other patient, whose recordings demonstrated short bursts of supraventricular 
tachycardia (SVT), had a total of 13 rhythm strips read as unclassified.  The remaining 84 
recordings were made up of a combination of sinus rhythm with premature atrial contractions 
(34), sinus rhythm with a significant number of premature ventricular contractions (30), or 
simply had too much artifact to be interpreted (20).   
 
Table 6: Rhythm Recordings 
 
 
Of the 43 patients, 17 required medication titrations.  Interestingly, 3 of the 17 patients 
were thought to be rate-controlled; additionally, they were asymptomatic and experiencing high 






more than 60 miles from Las Vegas, required assistance with medication titration.  This was 
accomplished by coupling the use of the KM device with the virtual platform; communication 
resulted in several adjustments to medications and prompted a referral to an electrophysiologist 
for consideration of ablation.  One other patient has since converted back to sinus rhythm, and 
the third is still in the process of medication adjustment.  During the monitoring period, two 
patients had cardiac ablation, a procedure that results in the scarring of cardiac tissue to disrupt 
faulty electrical conduction; to date, both have remained in sinus rhythm.   
Another patient, who had an episode of lone AF 15 years prior, presented with 
palpitations and dyspnea.  Her primary cardiologist, instead of arranging for a Holter or event 
monitor, which would have taken several weeks to schedule, referred her for the KM program.  
Within 14 days of enrollment, two recordings of AF with RVR were captured with reported 
symptoms of fatigue, shortness of breath, and chest discomfort.  Her medications have since 
been changed, and she has remained in sinus rhythm with acceptable rates.   
One patient who was being monitored for palpitations was noted to have daily bursts of 
SVT.  His medications were adjusted, and the frequency of these bursts significantly decreased.  
Of note, this same patient was diagnosed with new-onset AF within 24 days of enrollment and 
has since been started on anticoagulation for stroke risk reduction.   
Other Findings.  Additional findings revealed 97% (32) of respondents felt the program 
improved direct access to their cardiology provider; 100% felt the program increased the ability 
to communicate with their provider and healthcare team with an overall average of 4.8.  This was 
measured using a 1-5 Likert scale with ‘1’ indicating no increased access, and ‘5’ indicating 






Furthermore, 87% (29) felt the program reduced unnecessary visits to the ER, and 87% (29) felt 
empowered by the program to manage their healthcare concerns.      
Summary     
In summary, there was no statistical significance demonstrated in pre- and post-scores for 
anxiety or depression; however, there was a reduction in self-reported anxiety and increased 
satisfaction with the ability to communicate with the healthcare team as well as access to a 
cardiology provider.  Multiple transmissions of ECGs were recorded with care provided, as 
needed.  Lastly, patients felt this program reduced unnecessary ER visits and felt empowered to 









 Clinical Relevance.  This DNP project is relevant to any patient who has been diagnosed 
with AF or someone who experiences palpitations.  Of all symptoms associated with AF, one 
singularly unaddressed symptom is anxiety.  The KM device, monitored by an expert clinician, is 
a convenient and cost-effective way to decrease anxiety associated with a patient’s rhythm and 
rate due to AF.  Patients’ data can be measured at any time, and from anywhere, with the use of a 
smartphone; however, the component of the provider’s immediate intervention should not be 
underestimated.  Remote monitoring has the potential to extend its reach to rural and 
underserved areas, where there may be few clinicians.  This distance monitoring was 
demonstrated by those patients who sent recordings from the neighboring city of Pahrump, while 
on a cruise vacation, and from other countries such as Mexico.   
The KM device is a tool that is affordable, easy to use, and reliable in monitoring rate and 
rhythm.  With it, patients who were thought to be rate-controlled were identified as experiencing 
HVRs.  The significance of rate control translates to hemodynamic stability and prevention of 
tachycardia-induced cardiomyopathy, which may further result in heart failure.  Cardiac 
decompensation, in the absence of rate-control, can result in symptoms experienced by the 
patient and further drive healthcare expenditure.  Notwithstanding the advantages of the 
technology used, the value of the expert clinician is a critical component of this type of care 
delivery. 
 Limitations.  The project was limited by the number of participants as well as the time-






practice who may, or may not, have been previously diagnosed with AF.  Also, patients who had 
already purchased the KM device, on their own, may be a limitation as they had prior experience 
with device use; therefore, they may have already experienced reduced levels of anxiety.  
Further, ER visits were compared to a 12-month period; however, if the project were to be 
repeated, equal time-frames pre- and post- should be examined as opposed to this particular 
project, which was limited due to time constraints.  
The KM device, itself, has some limitations.  Three recordings were read as possible 
atrial fibrillation.  Upon review, the recordings were noted as sinus rhythm with frequent 
premature atrial contractions.  As previously mentioned, patients with a baseline of sinus 
arrhythmia or bundle branch blocks were read as unclassified; however, the KM algorithm is 
indicated for the detection of AF only.  Patients with atrial flutter and regular R to R intervals 
were often interpreted as normal.  Further, those with permanent pacemakers are not able to use 
the device as it creates interference or noise that results in an unreadable interpretation.   
Patients with movement disorders, such as Parkinson’s disease, may not be capable of 
producing a quality recording as patients must remain stationary for a period of 30 seconds.  The 
KM device does not have the capability for continuous monitoring; therefore, patients who 
require observation around-the-clock would necessitate a traditional Holter or event monitor. 
Relationship Among Project Results to Evidence and Theory.  Lakey’s (2016) 
framework offered guidance on the changes required to implement this project.  The first stage, 
cultural preparation, commenced with the formulation of a plan to improve patient outcomes, 
and reduce resource utilization.  The second stage, organizational building, required the team to 






appointments, document changes to the treatment plan, and how patients’ recordings would be 
reviewed and stored in the electronic medical record.  Once this process was developed, 
collaboration among the cardiology and OnDemand departments took place to discuss how to 
utilize the Internet platform for scheduling visits for face-to-face encounters.  Subsequently, 
there was a discussion with regard to reimbursement and how to code and bill for remote 
physiologic monitoring.   
Promoting this DNP project is the third stage, which was met with minimal opposition.  
The opposition was directed towards having to learn how to use a new platform in managing 
patients; however, key stakeholders were enthusiastic about the progressive means to decrease 
the use of resources with smartphone technology.   
The project is currently in the fourth stage, mass adoption.  Patients, after having used the 
KM device, and experienced virtual face-to-face visits, have become spokespersons for this new 
methodology.  Moreover, the other cardiology providers within the practice have started 
promoting its use.  This alternative access to healthcare offers unprecedented and unparalleled 
convenience, as patients stay in the comfort of their own homes.  The fifth stage, parallel 
institution, will become a means to supplement in-person visits.  While parallel institutions will 
not replace the gold standard of an in-person visit, it will provide a means to supplement the in-
person visit to improve patient satisfaction, reduce anxiety, and decrease the use of resources.   
Potential for Sustainability.  As we move towards incorporating this project into our 
usual practice, we have identified other personnel, cardiovascular technicians (CVTs), who will 
assist in reviewing ECGs.  There has been discussion with regard to uploading rhythm 






transferring an ECG into a patient’s chart; once a provider confirms the interpretation, it will be 
available, for immediate review, in the electronic medical record.     
The Medicare rates of reimbursement, in 2019, for result interpretation of a Holter 
monitor by a cardiologist was $27.13 (billing code 93227), and $26.03 for an event monitor 
(billing code 93272).  There is an additional fee of $9.49 (billing code 93270) for the initial 
hook-up charge, which is typically done by a CVT, and a charge for the use of the device itself, 
$26.72 (billing code 93255).  The total charge for hook up, one-time device use, and cardiologist 
interpretation for a Holter is $63.34, and $62.24 for an event monitor (Julia Somerville-Reeser, 
personal communication, February 3, 2020).   
The current company used for Holter and event monitors is Preventice Solutions.  
Preventice Solutions is a remote cardiac arrhythmia service that uses data analytics, machine-
learning capabilities, and cloud-based infrastructure to provide data reports to healthcare 
professionals (“Preventice Solutions,” n.d.).  The current pricing of a 24-48-hour Holter monitor 
is $70; for a long-term Holter, which is worn for more than 48 hours and up to 7 days, the charge 
is $225, and $230 for an event monitor.  The total cost for the one-time use of a Holter monitor 
with hook-up and interpretation is $133.34, and $287.24 for a one-time use event monitor.  A 
patient belonging to a Medicare Advantage plan pays $150 copay for an event monitor and $5 
copay for a Holter monitor.  For less than the copay price of an event monitor, a patient could 
own a KM device.  Further, the cost to the health plan for a one-time use device, whether it is a 
Holter or an event monitor, is higher than the cost of a KM device.    
Incorporating KardiaPro, for future use, the charge for the device and a one-year 






thereafter.  As of February 19, 2020, the organization the DNP student is employed by began to 
bill for remote patient monitoring; however, only one code has been approved for use to date.  
The billing code 99457 is used for remote physiologic monitoring (RPM), with a minimum of 20 
minutes of treatment and management per month.  This code has a reimbursement rate of $51.54 
(Svetlana Barbarash, personal communication, February 13, 2020).   
There are additional codes, such as:  
 99453: RPM set up and education, with a one-time reimbursement rate of $19.46 
 99454: Device supply with daily recordings or programmed alert transmission, 
billed every 30 days, has a reimbursement rate of $64.15 
 CPT 99091 can be billed by qualified healthcare professionals and requires a 
minimum of 30 minutes dedicated to the patient over the course of 30 days; 
however, it does not require interactive communication between the patient and 
the healthcare professional, as does billing code 99457.  In addition, CPT 99091 
cannot be billed concurrently with 99457 (“CPT Codes,” 2019).  
  While these RPM codes are available, the organization has not approved billing to date; 
however, it is safe to postulate that even with only the reimbursement of $51.54 per month, the 
device and use of KardiaPro would pay for itself.  Over twelve months, $51.54 as a baseline 
reimbursement rate, would generate $618.48 of revenue.  At this rate, 76 patients would need to 
enroll to cover a full-time equivalent for a staff member with a rate of pay of $22 per hour; this 
can easily be accomplished.  Moreover, once the additional codes are implemented, the 
reimbursement would amply cover the cost of additional support staff.  To provide further 






improve, as many patients do not require around-the-clock monitoring.  Most importantly, with 
close outpatient monitoring, anxiety, and healthcare costs can be reduced. 
Implication for Practice  
 This DNP project provided evidence that anxiety related to atrial fibrillation can be 
reduced and managed outpatient.  Further, patients living in remote areas, or traveling to other 
cities and countries, maybe managed from a distance with the use of the KM device, a 
smartphone application, and clinician oversight.  Patients feel they have better access to their 
cardiology providers and report feeling empowered to manage their healthcare concerns.  
Dissemination of Results  
 This DNP project will be submitted to the Western Institute of Nursing (WIN) as a poster 
presentation for the 2020 Research Conference.  This organization was chosen as follow up to 
the DNP proposal poster presentation given in April 2019.  Additionally, these findings will be 
disseminated at the American College of Cardiology 2020 Scientific Sessions conference, 
Cardiovascular Team Section, in Chicago, Illinois; also, as a follow up to the poster presentation 
given in March 2019.  Lastly, the DNP student will meet with her employer’s operational leaders 
to pitch a proposal to support the incorporation of digital technology, specifically the KM device, 
to empower and improve outcomes for patients with AF as well as support reduction in the use 
of healthcare resources and improving access to cardiology providers.   
Suggestions for Further Research 
Asymptomatic AF has become increasingly common in the aging population and may not 






screening patients with the use of the KM device may provide early detection of asymptomatic 
AF.  Early identification may curtail potential catastrophic events, further decreasing healthcare 
expenditure.  Additionally, and more particularly related to this project, further research using 
the KM device, with a larger cohort, and for an extended period of time is warranted to evaluate 
anxiety-related to atrial fibrillation, patient satisfaction with access to care, and the overall 
reduction of resource utilization.   
Summary 
Atrial fibrillation is the most common arrhythmia and has become increasingly common 
in the aging population.  It affects more than 6 million people, and the number is expected to 
double by 2050; with it, the economic burden associated with this disease process will also 
increase.  When patients experience symptoms or have increased anxiety, they may present to an 
acute care facility, which is often unnecessary.    
Mobile technology can assist in eliminating these unnecessary visits and further remove 
access to care barriers and assist with clinical oversight.  The use of the KM device is one 
method that was proven to deter unnecessary visits to the urgent care or emergency room, 
thereby decreasing overall expenditure and improving patient satisfaction.   
Additionally, silent AF is a concern as it may not be evident until the patient experiences 
a devastating event.  Patients 65 years of age or older may benefit, with the use of the KM device 
and clinician oversight, by submitting recordings for routine screening, which would allow for 
early detection of AF.  Early identification in asymptomatic patients may curtail potential 
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A Nurse Practitioner with experience working in an outpatient Cardiology department for a 
large, multispecialty group.  Prior to transitioning to Cardiology, I worked in a demanding urgent 
care clinic.  Preceding commencement, I was as a registered nurse with a culmination of fifteen 
years of clinical and administrative experience in a variety of areas which include Urgent Care, 
Hospice, CVIMC, and Cath Lab Recovery.  
 
Education 
Cardiology Nurse Practitioner  
Duke University, Conferred: May 2019 
 
MSN, Nursing, Family Nurse Practitioner                  
University of Nevada Las Vegas, Conferred: May 2015 
 
BSN, Nursing                                                            
University of Nevada Las Vegas, Conferred: May 2000 
Licensure  
Nevada APRN002010, expiration August 2020 
Nevada RN35102, expiration August 2020 
Nevada State Board of Pharmacy, APRN Prescribe, PRO2523 




American Nurses Credentialing Center Certification, Family Nurse Practitioner #2014035465, 
expiration July 2020 
 
Basic Life Support, expiration January 2021 
Advanced Cardiac Life Support, expiration September 2019 
Pediatric Advanced Life Support, expiration September 2020 
 
Forensic Nurse Certification, Kaplan University, August 2009 
Critical Care Certification, Sunrise Hospital, July 2000  






Professional Experience  
 
October 2016 – present: Cardiology Nurse Practitioner  Las Vegas, NV 
Southwest Medical Associates    
 
October 2015 – October 2016: Urgent Care Nurse Practitioner  Las Vegas, NV 
Southwest Medical Associates 
 
January 2012 – October 2015: RN Manager Urgent Care   Las Vegas, NV 
Southwest Medical Associates 
 
September 2009 – January 2010: Interim Urgent Care/24 hour - Close Observation 
Unit/Treatment Center Manager       Las Vegas, NV 
Southwest Medical Associates 
 
April 2007 – January 2012: RN Team Lead-Urgent Care   Las Vegas, NV 
Southwest Medical Associates  
 
December 2004 – April 2007: RN Patient Care Manager    Las Vegas, NV 
Solari Hospice Care 
 
August 2004 – December 2004: RN Case Manager  Las Vegas, NV 
Solari Hospice Care 
 
April 2002 – August 2004: CVIMC Charge Nurse     Las Vegas, NV 
Sunrise Hospital  
 
February 2002 - August 2003: Cath Lab Recovery Nurse    Las Vegas, NV 
Sunrise Hospital 
 
September 2001 - September 2002: CVIMC Relief Charge Nurse (full time acting)  
Sunrise Hospital          Las Vegas, NV 
 
June 2000 - September 2001: CVIMC Staff Registered Nurse  Las Vegas, NV 
Sunrise Hospital 
 
Position Duties Involved:  
APRN 
 Working collaboratively with cardiologists, and ancillary staff members, to provide 
outpatient management for a broad range of cardiovascular disease processes to 
include the ordering of diagnostic procedures, titration of medications, and referrals 
to interventionalists.  
 Formulate differential diagnoses and treatment plans for patients across the lifespan; 






radiology with capability to perform ultrasound and CT.  Minor procedures 
performed: suturing, intra-articular injections, I&D, lipoma/sebaceous cyst removals. 
 
RN Supervisory Roles   
 Working collaboratively with the interdisciplinary team to provide quality patient care 
by achieving a positive balance of healthcare, cost outcomes and patient satisfaction 
via supervision of operations, performance measures, clinical staff, and clinical 
support personnel.   
 Spearheading numerous initiatives for improving the quality of care and services 
delivered within the community to include annual flu clinics, volunteer opportunities, 
and multiple health fairs to promote primary prevention/screening.  
 Direct supervision and deployment of multiple corporate initiatives such as the 
implementation of Core Measures in the UC, On-line waiting program, Paperless 
Project, UC Patient Tracking Board, Now Clinic/Telemedicine, Lean initiative, and 
the opening of multiple new clinic sites.   
 Providing/creating educational tools for the urgent care staff, which were routinely 
implemented across all clinical sites (6 urgent cares/7 convenient cares).   
 Perform routine facility audits, knowledge of regulatory standards, and the insurance 
industry.   
 Maintain operation of a 24-hour Urgent Care with Treatment Center to provide 
outpatient long-term infusions to include chemotherapy, blood products, and IV 
diuresis; Close Observation/Chest Pain Unit to rule out cardiac events with the use of 
serial troponin, EKG, and 23-hour observation. 
 Co-Chair of Code Committee, member of Policies and Procedures Committee, 
Product Standardization Committee, and Skills Lab for newly hired staff. 
 
RN  
 Provided in-home nursing care to terminally-ill patients.  Home visits made with the 
interdisciplinary team.  Education of fellow health care professionals and the 
community in palliative care, and the hospice philosophy.   
 Monitored acute patients on telemetry, use of restricted cardiac medications, first 
responder for code situations.  Maintained and discontinued arterial and venous 
sheaths.   
 
Professional Memberships 
American College of Cardiology, Cardiovascular Team Member, Nevada Chapter, 
member ID: 3241312, current  
APRN Advisory Committee, Nevada State Board of Nursing, July 2017 to present 
American Association of Nurse Practitioners (AANP), member ID: 1303715, current 
American Nurses Association, member ID 03108300, current  







Nevada Advanced Practice Nurses Association (NAPNA), member ID: 691291, Vice 
President 2016 
Nevada Nurses Association, District NV03, Member ID 03108300, current 
Sigma Theta Tau, International Nursing Honor Society Zetta Kappa Chapter, member ID: 
1228547, current 
Emergency Nurses Association, member ID: 882378, to 2016 
 
Honors & Awards  
 Poster Presentation at the Western Institute of Nursing, April 2019, San Diego, 
CA.  Management of Atrial Fibrillation with Smartphone Technology 
 Poster Presentation at the American College of Cardiology Conference, March 
2019, New Orleans, LA.  Management of Atrial Fibrillation with Smartphone 
Technology 
 Sage of Clinical Services UnitedHealth Group 2018 
 American Association of Nurse Practitioners Nevada Advocate State Award for 
Excellence 2018 
 Most outstanding UNLV FNP student 2015 
 March of Dimes Nurse of the Year - Nursing Management, runner up, 2015 
 Named as Top 100 Managers based on “Vital Signs” within United Healthcare 
Group 2015 
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